Index of reports
> Cases with Maternal Exposure During Pregnancy (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Pregnyl (Chorionic Gonadotropin) where reactions include maternal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Pregnyl side effects in
Reported by a physician from Turkey on 2012-07-18
Patient:
Reactions: Drug Ineffective, Maternal Exposure During Pregnancy, Abortion
Drug(s) suspected as cause:
Clomiphene Citrate
Dosage: 50-150 mg
Indication: Ovulation Induction
Pregnyl
Dosage: 10000 iu
Indication: Ovulation Induction
Puregon
Dosage: 75 iu - 675 iu
Indication: Ovulation Induction
Possible Pregnyl side effects in
Reported by a physician from Turkey on 2012-07-18
Patient:
Reactions: Drug Ineffective, Maternal Exposure During Pregnancy, Ectopic Pregnancy
Drug(s) suspected as cause:
Clomiphene Citrate
Dosage: 50-150 mg
Indication: Ovulation Induction
Pregnyl
Dosage: 10000 iu
Indication: Ovulation Induction
Puregon
Dosage: 75 iu - 675 iu
Indication: Ovulation Induction
Possible Pregnyl side effects in female
Reported by a physician from Japan on 2012-03-02
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Ovarian Torsion, Maternal Exposure During Pregnancy, Abortion Induced, Ovarian Hyperstimulation Syndrome, Benign Hydatidiform Mole
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clomifene
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-08
End date: 2011-02-12
Gonal-F RFF PEN
Indication: Ovulation Disorder
Gonal-F RFF PEN
Indication: Polycystic Ovaries
Start date: 2011-02-14
End date: 2011-02-19
Pregnyl
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-20
End date: 2011-02-20
|